More resources needed for medication-assisted treatment March 14, 2017By Tracey WalkerInclude medication-assisted treatment high on the list of clinical tools used to treat opioid addiction. ACA reform must preserve mental health pharmacy access March 12, 2017By John FigueroaACA repeal or replacement must focus on how to preserve mental health services and pharmacy access. Cannabinoid-based drug pipeline shows promiseNew treatment indications are under investigation for the use of cannabinoid-based drugs. New strategies for managing drug spend: RA, Cancer, Hep C
March 04, 2017The proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Cannabinoid-based drug pipeline grows: 4 ways to prepareNew treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready? Payers to pharma: Here’s what we’re missing in hep C drugs February 17, 2017By Tracey WalkerA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment. Express Scripts’ 2016 Drug Trend Report: 7 things to know February 13, 2017By Tracey WalkerReport highlights spending trends in key areas, including specialty medications, oncology, diabetes, and inflammatory conditions. Ten ways the FDA is addressing the opioid epidemic February 11, 2017By Aubrey WestgateScott Winiecki, MD, of the FDA Center for Drug Evaluation and Research, shares how the FDA is working to address the opioid epidemic. Top strategies for incorporating PDMP data into physician work flow February 09, 2017By Aubrey WestgateHow can physicians, already struggling to keep up with mounting regulations and larger patient loads, use PDMPs in more effective and efficient ways? New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.